Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

China Health Labs & Diagnostics Ltd CHLBF

Healthcare Medical Devices


GREY:CHLBF - Post by User

China Health Labs & Diagnostics Ltd > Thomson Reuters StockReports+
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by reggiemanon Nov 28, 2012 3:04pm
346 Views
Post# 20656431

RE: Thomson Reuters StockReports+

RE: Thomson Reuters StockReports+

Now The average score is 9. The difference is price momentum change to 7 from 3.  Last year after Q3 (2011) Total Revenue was 25,6 M. This year after Q2 (2012)  Revenue 16,2 M + 11.6 M contract on october 2012 for a Total Revenue of 27,8 M. Make your DD.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities